The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP

Brown, 2001, The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP), Hypertens Pregnancy, 20, ix, 10.3109/10641950109152635

Roberts, 2013, If we know so much about preeclampsia, why haven’t we cured the disease?, J Reprod Immunol, 99, 1, 10.1016/j.jri.2013.05.003

Brown, 2012, Pre-eclampsia: proteinuria in pre-eclampsia –does it matter any more?, Nat Rev Nephrol, 8, 563, 10.1038/nrneph.2012.190

Staff, 2013, Redefining preeclampsia using placenta-derived biomarkers, Hypertension, 61, 932, 10.1161/HYPERTENSIONAHA.111.00250

Lowe, 2009, Guidelines for the management of hypertensive disorders of pregnancy 2008, Austr N Z J Obstet Gynaecol, 49, 242, 10.1111/j.1479-828X.2009.01003.x

Visintin, 2010, Management of hypertensive disorders during pregnancy: summary of NICE guidance, BMJ, 341, c2207, 10.1136/bmj.c2207

Excellence NNIfHaC. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy 2010 31/7/12.

Practice Bulletin No. 125: Chronic Hypertension in Pregnancy. Obstetrics & Gynecology. 2012;119(2, Part 1), pp. 396–407, doi: 10.1097/AOG.0b013e318249ff06.

von Dadelszen, 2010, The active implementation of pregnancy hypertension guidelines in British Columbia, Obstet Gynecol, 116, 659, 10.1097/AOG.0b013e3181eb669d

Magee, 2008, Hypertension guideline C, strategic training initiative in research in the reproductive health sciences S. diagnosis, evaluation, and management of the hypertensive disorders of pregnancy, J Obstet Gynaecol Canada, 30, S1, 10.1016/S1701-2163(16)32776-1

Redman CWG JS-L, Russell R. Hypertension in Pregnancy. In: Powrie R GM, Camann W, editor. de Swiet’s Medical Disorders in Obstetric Practice. 5th Edition ed: Blackwell Publishing; 2010. p. 153–81.

Waugh, 2002, Hidden errors of aneroid sphygmomanometers, Blood Pressure Monit, 7, 309, 10.1097/00126097-200212000-00003

Brown, 2011, Can we use the Omron T9P automated blood pressure monitor in pregnancy?, Hypertens Pregnancy, 30, 188, 10.3109/10641955.2010.507854

http://www.dableducational.org/index.html.

Nouwen, 2012, Validation of the Omron M7 and Microlife 3BTO-A blood pressure measuring devices in preeclampsia, Hypertens Pregnancy, 31, 131, 10.3109/10641955.2010.544799

Lindheimer, 2010, Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach, Obstet Gynecol, 115, 365, 10.1097/AOG.0b013e3181cb9644

Cote, 2008, The 24-hour urine collection: gold standard or historical practice?, Am J Obstet Gynecol, 199, 10.1016/j.ajog.2008.06.009

Cote, 2008, Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review, BMJ, 336, 1003, 10.1136/bmj.39532.543947.BE

Saudan, 1997, Improved methods of assessing proteinuria in hypertensive pregnancy, Br J Obstet Gynaecol, 104, 1159, 10.1111/j.1471-0528.1997.tb10940.x

Cade, 2012, The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia, Austr N Z J Obstet Gynaecol, 52, 179, 10.1111/j.1479-828X.2011.01409.x

Morris, 2012, Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis, BMJ, 345

Phelan, 2004, A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia, Hypertens Pregnancy, 23, 135, 10.1081/PRG-120028289

Tranquilli, 2013, The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Pregnancy Hypertens, 3, 44, 10.1016/j.preghy.2012.11.001

Homer, 2008, Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension, J Hypertens, 26, 295, 10.1097/HJH.0b013e3282f1a953

Payne, 2011, PIERS proteinuria: relationship with adverse maternal and perinatal outcome, J Obstet Gynaecol Canada, 33, 588, 10.1016/S1701-2163(16)34907-6

Lane, 2006, Can spot urine protein/creatinine ratio replace 24h urine protein in usual clinical nephrology?, Nephrology, 11, 245, 10.1111/j.1440-1797.2006.00564.x

Saudan, 1998, Does gestational hypertension become pre-eclampsia?, Br J Obstet Gynaecol, 105, 1177, 10.1111/j.1471-0528.1998.tb09971.x

Holston, 2009, Circulating angiogenic factors in gestational proteinuria without hypertension, Am J Obstet Gynecol, 200, 10.1016/j.ajog.2008.10.033

Franklin, 2013, White-coat hypertension: new insights from recent studies, Hypertension, 62, 982, 10.1161/HYPERTENSIONAHA.113.01275

Brown, 2001, Is resistant hypertension really resistant?, Am J Hypertens, 14, 1263, 10.1016/S0895-7061(01)02193-8

Brown, 2005, The natural history of white coat hypertension during pregnancy, BJOG, 112, 601, 10.1111/j.1471-0528.2004.00516.x

Baweja, 2011, Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography, BJOG, 118, 1126, 10.1111/j.1471-0528.2011.02960.x

Kleinrouweler, 2012, Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis, BJOG, 119, 778, 10.1111/j.1471-0528.2012.03311.x

Di Lorenzo, 2012, First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia, Placenta, 33, 495, 10.1016/j.placenta.2012.03.003

Myatt, 2012, First-trimester prediction of preeclampsia in nulliparous women at low risk, Obstet Gynecol, 119, 1234, 10.1097/AOG.0b013e3182571669

Masoura, 2012, Biomarkers in pre-eclampsia: a novel approach to early detection of the disease, J Obstet Gynaecol, 32, 609, 10.3109/01443615.2012.709290

Saftlas, 2003, Abortion, changed paternity, and risk of preeclampsia in nulliparous women, Am J Epidemiol, 157, 1108, 10.1093/aje/kwg101

Skjærven, 2002, The interval between pregnancies and the risk of preeclampsia, N Engl J Med, 346, 33, 10.1056/NEJMoa011379

Kho, 2009, Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome, J Reprod Immunol, 82, 66, 10.1016/j.jri.2009.04.011

North, 2011, Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort, BMJ, 342

Parra-Cordero M, Rodrigo R, Barja P, Bosco C, Rencoret G, Sepúlveda-Martinez A, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during the first trimester of pregnancy. Ultrasound Obstet Gynecol. 2012:n/a-n/a.

Lykke, 2012, Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort, J Thromb Haemost, 10, 1320, 10.1111/j.1538-7836.2012.04773.x

Rana, 2012, Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia/clinical perspective, Circulation, 125, 911, 10.1161/CIRCULATIONAHA.111.054361

von Dadelszen, 2011, Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model, Lancet, 377, 219, 10.1016/S0140-6736(10)61351-7

Payne, 2013, Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission, BJOG, 120, 113, 10.1111/j.1471-0528.2012.03496.x

Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD004659.pub2

Hofmeyr, 2010, Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems., Cochrane Database Syst Rev, 8, 10.1002/14651858.CD001059.pub3

Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis. Obstetrics & Gynecology. 2010;116(2, Part 1), pp. 402–14, doi: 10.1097/AOG.0b013e3181e9322a.

Rumbold, 2008, Antioxidants for preventing pre-eclampsia, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD004227.pub3

Hawkins, 2012, Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study, BJOG, 119, 484, 10.1111/j.1471-0528.2011.03232.x

Roberts, 2005, Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension, Hypertension, 46, 1263, 10.1161/01.HYP.0000188703.27002.14

Moser, 2012, Hypertension in pregnancy: is it time for a new approach to treatment?, J Hypertens, 30, 10.1097/HJH.0b013e3283536319

Duley, 2010, Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, Cochrane Database Syst Rev, 11

Group TMTC. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. The Lancet. 2002;359(9321):1877–90.

Brown M. Is there a role for ambulatory blood pressure monitoring in pregnancy? Clin Exp Pharmacol Physiol. 2013:n/a-n/a.